Omneer is building the future of personalized medicine tools and analytics for neuroscience from multiomics data. Our focus is on using this multiomics data for advanced prediction of neurodegenerative diseases and the creation of personalized treatments, or "digital twins".

We want to revolutionize the way neurodegenerative diseases are diagnosed and treated. In the digital realm of neuroscience, we are creating a data infrastructure that will serve as an invaluable tool for physicians and researchers alike.

Current practices in neurodegenerative disorders diagnosis, such as Parkinson's and Alzheimer's, rely heavily on qualitative evaluations. Unfortunately, this approach often results in significant diagnostic delays and inaccuracies. The need for a more precise, proactive, and personalized system is crying out.

Omneer's advanced analytics platform bridges this gap. By leveraging multiomics data, we are revolutionizing the way neurodegenerative diseases are predicted, diagnosed, and treated. Our mission-critical features include:

• Early Prediction: By harnessing the power of big data, machine learning, and sophisticated neuroimaging, Omneer facilitates the early detection of neurodegenerative diseases. Our algorithms are designed to identify patterns at the earliest stages of diseases, even before the onset of noticeable symptoms.

• Disease Progression: With our continuous and automated data analysis, we track the progression of the disease meticulously. This offers healthcare providers a better understanding of the disease's course and the effectiveness of chosen treatment strategies.

• Personalized Treatment: Omneer is pioneering the creation of "digital twins", allowing for the simulation of multiple treatment scenarios to identify the most effective, personalized therapeutic approach. This revolutionary technique eliminates the trial-and-error methods commonly used in managing neurodegenerative disorders.

• Qualitative to Quantitative: We replace qualitative assessments with quantitative data analysis, reducing diagnostic delay and increasing the accuracy of diagnoses. Our auditable data and execution lineage provide reliable and reproducible results.

• An overview of the motivations and features of our Advanced Analytics Platform, [link here]
• How our platform fits into a broader BioDevelopment Framework, [link here]
• Advanced Analytics Platform source code, [link here]

The convergence of sophisticated neuroimaging, big data analytics, and machine learning is catapulting the domain of neurodegenerative disease diagnosis and personalized treatment into the digital realm.

Our mission at Omneer is to create and propagate the data infrastructure necessary for this neurodiagnostic revolution. We aim to empower physicians and researchers with the tools to predict, diagnose, and eventually halt neurodegenerative diseases in their tracks.

For a closer look at our vision, see the full mission here.

Follow the instructions in our Getting Started Guide to set up your environment and start using Omneer's Advanced Analytics Platform.

We welcome contributions to Omneer. If you're interested in contributing, please see our Contribution Guidelines.

If you have any questions, suggestions, or just want to say hello, feel free to contact us at contact@omneer.com.

Omneer is licensed under the MIT license. For more information, see the License file in our repository.